Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592799 | SCV000709295 | uncertain significance | not provided | 2017-06-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000592799 | SCV003334991 | uncertain significance | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 502520). This variant has not been reported in the literature in individuals affected with VIPAS39-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 409 of the VIPAS39 protein (p.Arg409Pro). |
Fulgent Genetics, |
RCV005010588 | SCV005635540 | uncertain significance | Arthrogryposis, renal dysfunction, and cholestasis 2 | 2024-05-31 | criteria provided, single submitter | clinical testing |